
Dexamethasone Phosphate disodium
CAS No. 2392-39-4
Dexamethasone Phosphate disodium ( EGP-437 | EGP 437 | EGP437. Dex-Phos )
产品货号. M26007 CAS No. 2392-39-4
地塞米松磷酸二钠是合成糖皮质激素地塞米松的水溶性形式。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
100MG | ¥332 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Dexamethasone Phosphate disodium
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述地塞米松磷酸二钠是合成糖皮质激素地塞米松的水溶性形式。
-
产品描述Dexamethasone disodium phosphate is a water-soluble form of the synthetic glucocorticoid dexamethasone.(In Vitro):Dexamethasone regulates several transcription factors, including activator protein-1, nuclear factor-AT, and nuclear factor-kB, leading to the activation and repression of key genes involved in the inflammatory response. Dexamethasone potently inhibits granulocyte-macrophage colony stimulating factor (GM-CSF) release from A549 cells with EC50 of 2.2 nM. Dexamethasone (EC50=36 nM) induces transcription of the β2-receptor is found to correlate with glucocorticoid receptor (GR) DNA binding and occurred at 10-100 fold higher concentrations than the inhibition of GM-CSF release. Dexamethasone (IC50=0.5 nM) inhibits a 3×κB (NF-κB, IκBα, and I-κBβ), which is associated with inhibition of GM-CSF release.(In Vivo):Treatment with Dexamethasone at a dose of 2×5 mg/kg efficiently inhibits lipopolysaccharide (LPS)-induced inflammation. In our experimental system, treatment with a single dose of Dexamethasone 10 mg/kg (i.p.) significantly decreases recruitment of granulocytes as well as spontaneous production of oxygen radicals compared with animals expose to LPS and injected with solvent alone (saline). The effects are statistically significant when administered both 1 h before and 1 h after inhalation of LPS. The number of granulocytes in BALF decreased to levels comparable to healthy animals (given an aerosol of water). Rats treated with Dexamethasone consume less food and weighed less than control rats. Treated rats also weigh less than pair-fed animals though their food intake is similar. Five days of Dexamethasone injection result in a significant increase in both the liver mass (+42%) and the liver to body weight ratio (+65%). The wet weight of gastrocnemius muscle decreases 20% after 5 days of treatment, but it remains unaffected relative to body weight (g/100 g body weight), indicating that muscle weight loss paralleled body weight loss.
-
体外实验——
-
体内实验——
-
同义词EGP-437 | EGP 437 | EGP437. Dex-Phos
-
通路Others
-
靶点Other Targets
-
受体MRGPRX1
-
研究领域——
-
适应症——
化学信息
-
CAS Number2392-39-4
-
分子量516.41
-
分子式C22H28FNa2O8P
-
纯度>98% (HPLC)
-
溶解度In Vitro:?H2O : ≥ 100 mg/mL (193.65 mM))
-
SMILES[Na+].[Na+].C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP([O-])([O-])=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Prchalová E, et al. Discovery of Benzamidine- and 1-Aminoisoquinoline-Based Human MAS-Related G-Protein-Coupled Receptor X1 (MRGPRX1) Agonists. J Med Chem. 2019 Sep 26;62(18):8631-8641.
产品手册




关联产品
-
Selaginellin F
Selaginellin F is a natural product from Selaginella pulvinata.
-
Selexipag(NS-304)
NS-304 是一种口服有效的 PGI(2) 受体(IP 受体)激动剂。
-
RET-IN-1
RET-IN-1 是一种 RET 激酶抑制剂,摘自专利 WO2018071447A1,化合物实施例 552,对于 RET (WT)、RET (V804M) 和 RET (G810R) 的 IC50 值分别为 1 nM、7 nM 和 101 nM。